CDKN2A and melanoma: For example, both the BRAF-mutant and RAS-mutant subtypes of melanoma have been successfully modeled in mice [9] and zebrafish [10] by combining the melanoma-associated mutations in these genes with mutation or loss of p53 or Cdkn2a, which are both typically inactivated in human melanoma [2, 11].